Latest news about encapsia

Latest message from our CEO on Cmed’s response to the Coronavirus (COVID-19) pandemic

Cmed reaches 20 years of zero downtime for clinical database services

Written by Cmed, 12 Dec 2019

Cmed Technology announces 20 years of clinical trial software provision and hosting with zero downtime.

Encapsia is Cmed’s clinical data suite designed around a unified clinical database with user-centric apps to support all trial processes and a full cloud architecture. The inherent flexibility of this structure means mid study protocol amendments or technical system updates can be made with no disruption for users. In this respect, much of the knowledge and experience of Cmed’s previous technology platform, Timaeus, was applied to encapsia.

No downtime has significant benefits for trial sites as they can enter data without interruption, avoiding one of the causes of data entry backlogs. The encapsia apps for EDC and direct data capture eSource are designed to be fast and user friendly, even coping with intermittent internet access at sites. In combination, these features mean trial sites report a better experience with encapsia.

With no delays in data entry and all data held in a single unified database, sponsors benefit from live views of trial data that can be actioned within encapsia, for example improving data monitoring and data review.

Dr Timothy Corbett-Clark, Chief Technology Officer of Cmed said “We’re delighted to reach our latest milestone with no system downtime for our clients for 20 years.

“No Downtime means continuous, uninterrupted access by users, 24 / 7, regardless of database updates, trial configuration changes, or system upgrades. Nobody expects social media to go down for updates, so why not expect the same from modern EDC systems too?”

Last 3 posts

The global COVID-19 crisis has fundamentally impacted the way we live our lives as well as the operation of the entire drug development community. As the crisis continues to evolve, the Cmed leadership team has already implemented a number of measures to ensure the safety of our employees, clients and partners, as well as ensuring the continued delivery of our CRO services and our encapsia clinical data system. Our goal being to minimise the impact of COVID-19 on our business, our clients, investigator sites and patients.
Thank you for your continued loyalty and trust in Cmed and encapsia during these uncertain times. We are continuously monitoring the evolving circumstances surrounding the COVID-19 outbreak and continue to operate as normal. ~ Our highest priority is to maintain the health and safety of our people, customers, partners and suppliers while meeting our service commitments. Cmed has implemented a range of measures in line with World Health Organization guidance to minimise the risks for employees and customers.
Direct Data Capture (DDC) is one of the four types of eSource (see previous post), and is often what people first think of as eSource. Direct data capture is the process of entering data into the eCRF contemporaneously, rather than transcribing from other sources such as paper or site EHR systems. Some technology providers believe that EDC systems can be used as eSource, where the web based EDC system is carried around on a laptop, or potentially a tablet, and data is entered directly into this system.